Clinical Trial Environmental Impact
CMC Ontology
Data FAIRy Bioassay Annotation
Global Substance Registration System
IDMP Ontology
In Vitro NAM Data Standards
In Vitro Pharmacology
Large Language Models in Life Sciences
NLP Use Case Database
Pharma General Ontology
Pharmacovigilance Systems and Processes Standards
Social Media Real World Evidence
Current Projects
Delivered Projects
AI / ML
Change Management
CSCS
Data Governance
FAIR
Future Labs Evolution
Microbiome-Mediated Drug Metabolism Database
Quantum Computing
UXLS
Current Communities
Delivered Communities
Delivered Projects and Communities
New Ideas
Username or Email Address
Password
Remember Me
Webinar
During this webinar we will share some of the key challenges and opportunities organizations face today, along with some examples of Pistoia Alliance member-driven initiatives to highlight the power of pre-competitive collaboration in advancing digitalization and automation on the path towards their Lab of the Future.
In this talk our speaker, Dimitris K. Agrafiotis, Vice President, Digital, Worldwide Research, Development and Medical, Pfizer will discuss some of the common challenges and pitfalls in visualizing data and highlight a number of analytic solutions that he and his teams have developed over his 30-year career in pharmaceutical R&D, reflecting on the design, engineering, and organizational principles that underpinned their success.
The aim of this community is to accelerate the adoption of quantum computing in the pharmaceutical industry. Our most recent community survey identified the lack of relevant use cases as the biggest barrier to adoption. This session will tackle this by looking at quantum use cases from leading organizations, and include a panel discussion to explore potential next steps for the industry.
This presentation is a call to ‘put data before visualization’. We show how simple ‘spaghetti’ plots offer a useful alternative to waterfall plots, in order to understand drug effects and support decision-making in early clinical development.
At the Pistoia Alliance, we are exploring how the FAIRification of such data, along with advanced analytics including AL/ML/NLP powered systems can be used to access/share/reuse patient data from historical clinical trials.
Plenary session
The complexity of manual data curation makes it a costly – but necessary – process, and that is why it is so important to get it right. This webinar will explore the processes, best practices, and pitfalls of manual curation.
Join our expert panelists as they explain the reasons they came together to define a framework that would support teams in understanding UX skillsets.
The Pistoia Alliance is bringing together two important communities— Data Governance and Lab of the Future—in a series of 3 webinars dedicated to the Data Standards – The Adoption of Common and Open Data Standards for the Lab of the Future.
Part of the Global Knowledge Sharing Webinars to provide some specific examples of where its pre-competitive collaboration model of shared-risk and shared-reward can bring value.
The Pistoia Alliance is bringing together two important communities— Data Governace and Lab of the Future in a series of 3 webinars dedicated to the Data Standards – The Adoption of Common and Open Data Standards for the Lab of the Future.
Although artificial intelligence (AI) has had a profound impact on areas such as image recognition, comparable advances in drug discovery are rare. We will discuss the stages of drug discovery in which improvements in the time taken, success rate or affordability will have the most profound overall impact on bringing new drugs to market.